Home
Contact Palatin
Site Map
.
.
.
.
.
.
Investor/Media Center
Overview
Press Releases
Event Calendar
Webcasts
SEC Filings
Analyst Coverage
Corporate Governance
Investor Materials
Corporate Fact Sheet
Webcasts
Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results
Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction Teleconference and Webcast to be held on Tuesday, May 14, 2013
(5/14/2013)
The Palatin
Technologies webcasts are powered by
Microsoft Windows Media™
.
Overview
Press Releases
Event Calendar
Webcasts
SEC Filings
Analyst Coverage
Corporate Governance
Investor Materials
Overview
Executive Management
Board of Directors
Overview
Career Opportunities
Overview
Press Releases
Presentations
Events Calendar
Webcasts
Media Kit
Overview
PL-3994 for CHF
PL-3994 for Asthma
PL-3994 for Hypertension
Bremelanotide
PL-6983
Obesity
Overview
Licensing and Collaboration Opportunities